Abbott实验室在2025年的季度2中每股收入为1.30美元,达到了预期,收入比同年增加6.9%。 Abbott Labs earned $1.30 per share in Q2 2025, met expectations, with revenue up 6.9% year-over-year.

Abbott实验室报告说,2025年第二季度的收益为每股1.30美元,达到预期水平,收入为113.7亿美元,比上一年增加6.9%。 Abbott Laboratories reported second-quarter 2025 earnings of $1.30 per share, meeting expectations, with revenue of $11.37 billion, up 6.9% year-over-year. 该公司将其全年2025年EPS指南提高到5.12至5.18美元,保持了强劲的盈利能力,净利润率为31.88%,股本回报率为17.78%。 The company raised its full-year 2025 EPS guidance to $5.12–$5.18, maintaining strong profitability with a 31.88% net margin and 17.78% return on equity. 该股票交易额为128.69美元,市场上限为2233.98亿美元,P/E比率为16.13。 The stock, trading at $128.69, has a market cap of $223.98 billion and a P/E ratio of 16.13. 分析师按147.61美元的目标对它进行“机动购买”的评级,该公司宣布季度股息为每股0.59美元。 Analysts rate it a "Moderate Buy" with a $147.61 target, and the company declared a quarterly dividend of $0.59 per share. 机构所有权仍然很高,占75.18%。 Institutional ownership remains high at 75.18%.